[HTML] frontiersin.org

[HTML][HTML] iPSC-derived natural killer cell therapies-expansion and targeting

BH Goldenson, P Hor, DS Kaufman - Frontiers in immunology, 2022 - frontiersin.org
Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen rapid
development, especially use against hematologic malignancies. Clinical trials of NK cell …
被引用次数：68 相关文章
[HTML] nih.gov

[HTML][HTML] iPSC-Derived Natural Killer Cell Therapies-Expansion and Targeting

BH Goldenson, P Hor, DS Kaufman - Frontiers in Immunology, 2022 - ncbi.nlm.nih.gov
Abstract Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen rapid
development, especially use against hematologic malignancies. Clinical trials of NK cell …

iPSC-Derived Natural Killer Cell Therapies-Expansion and Targeting

BH Goldenson, P Hor… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen rapid
development, especially use against hematologic malignancies. Clinical trials of NK cell …

iPSC-Derived Natural Killer Cell Therapies-Expansion and Targeting

BH Goldenson, P Hor, DS Kaufman - Frontiers in Immunology, 2022 - cir.nii.ac.jp
抄録< jats: p> Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen
rapid development, especially use against hematologic malignancies. Clinical trials of NK …

iPSC-Derived Natural Killer Cell Therapies-Expansion and Targeting

BH Goldenson, P Hor, DS Kaufman - 2022 - escholarship.org
Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen rapid
development, especially use against hematologic malignancies. Clinical trials of NK cell …

iPSC-Derived Natural Killer Cell Therapies-Expansion and Targeting.

BH Goldenson, P Hor, DS Kaufman - Frontiers in Immunology, 2022 - europepmc.org
Abstract Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen rapid
development, especially use against hematologic malignancies. Clinical trials of NK cell …

iPSC-Derived Natural Killer Cell Therapies-Expansion and Targeting.

BH Goldenson, P Hor, DS Kaufman - Frontiers in Immunology, 2022 - europepmc.org
Abstract Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen rapid
development, especially use against hematologic malignancies. Clinical trials of NK cell …